Good Life Advisors LLC Lowers Stock Holdings in MetLife, Inc. (NYSE:MET)

Good Life Advisors LLC reduced its position in MetLife, Inc. (NYSE:MET) by 18.7% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,022 shares of the financial services provider’s stock after selling 1,156 shares during the quarter. Good Life Advisors LLC’s holdings in MetLife were worth $411,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently bought and sold shares of the company. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its holdings in shares of MetLife by 1.5% in the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 4,548,725 shares of the financial services provider’s stock valued at $375,179,000 after purchasing an additional 68,579 shares in the last quarter. Nordea Investment Management AB boosted its position in MetLife by 16.8% in the 4th quarter. Nordea Investment Management AB now owns 4,238,087 shares of the financial services provider’s stock valued at $347,735,000 after buying an additional 608,224 shares during the period. Swedbank AB grew its stake in shares of MetLife by 76.0% in the fourth quarter. Swedbank AB now owns 3,466,808 shares of the financial services provider’s stock worth $283,862,000 after acquiring an additional 1,496,645 shares in the last quarter. Jennison Associates LLC increased its position in shares of MetLife by 3.6% during the fourth quarter. Jennison Associates LLC now owns 3,274,258 shares of the financial services provider’s stock worth $268,096,000 after acquiring an additional 114,166 shares during the period. Finally, Stifel Financial Corp raised its stake in shares of MetLife by 5.0% in the third quarter. Stifel Financial Corp now owns 2,239,841 shares of the financial services provider’s stock valued at $184,744,000 after acquiring an additional 105,762 shares in the last quarter. 94.99% of the stock is currently owned by hedge funds and other institutional investors.

MetLife Trading Down 0.3 %

NYSE MET opened at $82.82 on Friday. The firm’s fifty day moving average price is $83.45 and its 200 day moving average price is $81.26. MetLife, Inc. has a 12 month low of $67.30 and a 12 month high of $89.05. The company has a debt-to-equity ratio of 0.54, a current ratio of 0.16 and a quick ratio of 0.16. The company has a market capitalization of $57.34 billion, a price-to-earnings ratio of 13.87, a price-to-earnings-growth ratio of 0.65 and a beta of 1.07.

MetLife (NYSE:MET) last posted its earnings results on Wednesday, February 5th. The financial services provider reported $2.08 EPS for the quarter, missing analysts’ consensus estimates of $2.13 by ($0.05). MetLife had a return on equity of 20.42% and a net margin of 6.19%. On average, sell-side analysts expect that MetLife, Inc. will post 9.65 earnings per share for the current fiscal year.

MetLife Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 11th. Shareholders of record on Tuesday, February 4th will be paid a $0.545 dividend. This represents a $2.18 dividend on an annualized basis and a yield of 2.63%. The ex-dividend date is Tuesday, February 4th. MetLife’s dividend payout ratio is currently 36.52%.

Analyst Ratings Changes

Several research analysts recently commented on the company. Wells Fargo & Company boosted their target price on MetLife from $92.00 to $97.00 and gave the stock an “overweight” rating in a research note on Wednesday. StockNews.com downgraded MetLife from a “buy” rating to a “hold” rating in a research report on Thursday, January 9th. Keefe, Bruyette & Woods reduced their target price on shares of MetLife from $100.00 to $98.00 and set an “outperform” rating on the stock in a report on Wednesday, February 12th. JPMorgan Chase & Co. boosted their price target on shares of MetLife from $86.00 to $88.00 and gave the stock an “overweight” rating in a report on Tuesday, January 7th. Finally, Barclays reduced their price objective on shares of MetLife from $96.00 to $95.00 and set an “overweight” rating on the stock in a report on Friday, February 7th. Two research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the stock. According to data from MarketBeat, MetLife currently has an average rating of “Moderate Buy” and an average price target of $92.58.

MetLife Company Profile

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.